Metraipolis › archive › dc_3486cc5ebd88

Enhancing Data Quality in Clinical Trials: Cross-Company Validation of the Open-Source Clinical Trial Anomaly Spotter (CTAS) — Europe PMC PMID:41817917

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41817917
DOI
10.1007/s43441-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-10-07T17:18:42.316Z
SHA-256 of the archived text
ae72fb35898c923e6d8f8772bda161c28d99ad1fa45abe6cc5d282dc35788de1
Stable URL of this page
https://metraipolis.com/documento/dc_3486cc5ebd88

How to cite

Enhancing Data Quality in Clinical Trials: Cross-Company Validation of the Open-Source Clinical Trial Anomaly Spotter (CTAS) — Europe PMC PMID:41817917 — Europe PMC (en), https://europepmc.org/article/MED/41817917 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3486cc5ebd88 (Metraipolis archive dc_3486cc5ebd88, sha256 ae72fb35898c923e6d8f8772bda161c28d99ad1fa45abe6cc5d282dc35788de1)
BibTeX
@misc{dc3486cc5ebd88,
  title = {Enhancing Data Quality in Clinical Trials: Cross-Company Validation of the Open-Source Clinical Trial Anomaly Spotter (CTAS) — Europe PMC PMID:41817917},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41817917},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3486cc5ebd88; sha256 ae72fb35898c923e6d8f8772bda161c28d99ad1fa45abe6cc5d282dc35788de1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41817917. Agents can read the archived copy with the MCP tool read_document.